The problem with guessing your dose

Every morning, the capsule goes down with breakfast. Vitamin D — because a podcast mentioned it, a friend recommended it, or the pharmacy shelf made it look harmless. What almost nobody does first is get a blood test.

That gap between good intention and actual calibration is the problem Professor Paul Lee addresses in Regeneration by Design, his Amazon number-one bestselling book and the scientific foundation of his regenerative-medicine work. Lee structures human health around four interdependent pillars — Physics, Chemistry, Biology, and Time. The Chemistry pillar covers nutrition, hormones, and the body's internal environment, and vitamin D sits squarely at its centre. His critique of modern supplement culture is blunt: he calls it 'Too Much, Too Blind.'

The phrase captures a real clinical paradox. Two people taking the same standard-dose capsule every winter morning may be in entirely different situations. One might be genuinely deficient and benefiting from the supplement; the other, already sitting at a healthy level, may quietly be pushing toward excess. Without a baseline blood test, neither of them knows which story is theirs — and the symptoms of deficiency and overdose can look identical.

Why vitamin D is really a hormone

Calling it a 'vitamin' is a misnomer that shapes how most people think about dosing — and how casually they approach it. Vitamin D is, technically, a fat-soluble secosteroid hormone, synthesised in the skin when UVB radiation strikes cholesterol, or taken in through diet and supplements as cholecalciferol (D3). Before the body can use it, the liver converts D3 into calcifediol — the form written on blood test results as 25(OH)D — which the kidneys then activate into calcitriol, the molecule that actually docks with receptors around the body.

Hormones do not stay in their lane. Calcitriol acts systemically: it regulates immune responses, governs muscle-cell function, and participates in metabolic signalling well beyond its familiar role in calcium absorption and bone mineralisation. Deficiency does not just weaken bones; it impairs muscle strength and co-ordination, nudges the immune system toward dysregulation, and disrupts metabolic pathways — all operating precisely within what the Chemistry pillar describes as the body's internal environment.

This reach is what makes casual dosing genuinely irrational. A classical vitamin, in deficit, is corrected by topping up. A hormone, mis-dosed, shifts a system-wide signalling network in ways that ripple outward. A small deviation in circulating 25(OH)D can have effects that are disproportionate to the dose — which is the foundational reason why knowing your starting level, before you add any more, is not excessive caution but basic biochemical logic.

The right biomarker — and how to test it properly

Serum 25-hydroxyvitamin D — written as 25(OH)D on a results sheet — is the established clinical biomarker for whole-body vitamin D status, not the active form calcitriol. Calcitriol fluctuates rapidly in response to calcium levels and circulates in vanishingly small amounts; it tells you little about your reserves. The 25(OH)D form, stable and reliably measurable, reflects what the body actually has available.

The method used to measure it also matters. Immunoassay-based tests, though widely used, vary meaningfully in accuracy between laboratories. Liquid chromatography–mass spectrometry (LC-MS) is the recognised reference standard — more precise, less susceptible to interference from other molecules. When booking a private blood test, asking whether the laboratory uses LC-MS is a reasonable consumer step rather than overcaution.

Once you have the result, UK reference ranges are clear: sufficient is ≥50 nmol/L, insufficient is 25–50 nmol/L, and deficient is below 25 nmol/L. A reading above roughly 250 nmol/L enters the range where toxicity risk becomes clinically relevant — which is why knowing your number before supplementing is more useful than discovering it afterwards.

A 25(OH)D test can be requested from a GP where clinical grounds exist — limited sun exposure, age over 60, darker skin tone, and malabsorption conditions are all accepted risk factors — or arranged privately through an accredited laboratory. For those who want vitamin D results read alongside the broader Chemistry picture — inflammation markers, hormonal indicators, metabolic function — the Regen PhD Biomarker Panel draws 32 markers at Harley Street, reviewed by a physician, so that one number sits within the full context of regeneration potential rather than in isolation.

Seasonal deficiency and the autumn baseline habit

October is the moment when the UK's northern latitude stops cooperating. UVB radiation — the band of sunlight that triggers vitamin D synthesis in the skin — becomes too weak to drive meaningful production from October through to March, a six-month window in which the body depends almost entirely on stored reserves and whatever arrives from food or supplements. The NHS, acknowledging this, advises a daily 10 µg (400 IU) supplement for the autumn and winter months.

But seasonal depletion is not uniform. How much it matters depends on how much sun a person actually captured during summer — itself a function of latitude, how much outdoor time work and habit allow, skin tone, and age (older skin synthesises vitamin D less efficiently). Two people following the same general guidance in November may arrive at Christmas with very different 25(OH)D readings.

For anyone in the 40–70+ range who already supplements year-round, early autumn is the most useful calibration point in the calendar. Before the winter shortfall compounds on top of whatever the summer produced, a single blood test reveals whether the current approach is working — holding the level steady, correcting a genuine gap, or pushing it higher than necessary. Testing in September or October does not require a health scare to justify it. It is simply the cleanest moment to know where you are before the sun stops helping.

The symptom-overlap trap — why too much is as misleading as too little

The symptoms of taking too much vitamin D look almost identical to the symptoms of taking too little. Fatigue, nausea, generalised weakness, frequent urination — the body's warning signals do not specify a direction. This is the crux of what makes unsupervised high-dose supplementation genuinely hazardous rather than merely inefficient.

Clinical evidence makes the risk concrete. A 2025 case report documented severe PTH-independent hypercalcaemia — corrected calcium of 16.3 mg/dL and a 25(OH)D reading of 340 ng/mL — in a man self-administering 25,000 to 50,000 IU daily for six months, guided by online content rather than blood results. A 2026 hospital study found vitamin D toxicity accounted for 20% of all hypercalcaemia admissions, driven by repeated high-dose oral regimens taken without monitoring. These are not remote edge cases; they are a pattern that Practical Regeneration names directly as the 'Too Much, Too Blind' problem.

The symptom-overlap trap has a single exit: a blood test. It is the reasoning behind Professor Paul Lee's precision-medicine stance in Regeneration by Design — that chemistry demands individual calibration, not population averages. Someone who is supplementing and feels unwell cannot rely on intuition to know which way to move. A 25(OH)D result tells them. If the number sits outside the expected range in either direction, a healthcare professional can advise on next steps rather than leaving the decision to guesswork.

From your result to a protocol that fits you

Once a 25(OH)D result is in hand, the question is no longer whether to supplement but how to calibrate. Each of the three result bands covered earlier carries a different prompt for action — though specific dosing decisions are best made with a practitioner who can weigh the full picture.

A reading in the deficient range calls for active intervention rather than the standard maintenance dose. Correction-level supplementation is typically higher than the NHS's 400 IU autumn-and-winter guidance and should be time-limited, followed by a retest within eight to twelve weeks to confirm the level is rising without overshoot. The insufficient band, where a substantial proportion of UK adults sit at any given time, warrants supplementation alongside seasonal habit changes; retesting after three months turns a one-off data point into a responsive protocol. At or above the sufficiency threshold, the goal shifts from correction to maintenance — and the autumn baseline tells you whether the current approach is actually holding that level steady.

One adjacent Chemistry consideration worth raising when reviewing the broader panel: magnesium. It acts as a cofactor in the conversion pathway through which vitamin D reaches its active form, and in the receptor function through which calcitriol signals in tissue. Serum magnesium is a standard marker that can be checked alongside 25(OH)D; if levels are low, supplementing vitamin D alone may deliver a blunted response. Dosing specifics are best confirmed with a practitioner.

This test-first logic is what Regeneration by Design encodes as precision chemistry — treating the body's internal environment as something to be read and adjusted, not guessed at. Professor Paul Lee's Regen PhD Biomarker Panel (32 markers, drawn at Harley Street and reviewed by a physician) builds the same feedback loop into a structured regeneration pathway across all four pillars. Knowing your 25(OH)D before the season changes does not just answer a supplement question; it closes the loop between intention and actual biochemical state — which is the only kind of optimisation that compounds over time.

This article provides general wellness information. For guidance on specific doses or clinical interpretation of results, consult a qualified healthcare professional.

1. [1] Vitamin D testing and treatment: a narrative review of current evidence. (2019). https://doi.org/10.1530/EC-18-0432 https://doi.org/10.1530/EC-18-0432
2. [2] Vitamin D. https://en.wikipedia.org/?curid=24998247 https://en.wikipedia.org/?curid=24998247
3. [3] Calcifediol. https://en.wikipedia.org/?curid=6832355 https://en.wikipedia.org/?curid=6832355
4. [4] Etiological Spectrum of Hypercalcemia in a North Indian Tertiary Care Center: Emerging Role of Vitamin D Toxicity. (2026). https://doi.org/10.7759/cureus.108257 https://doi.org/10.7759/cureus.108257
5. [5] Vitamin D deficiency. https://en.wikipedia.org/?curid=20840716 https://en.wikipedia.org/?curid=20840716
6. [6] MON-742 Less is More: Successful Conservative Management of PTH-Independent Hypercalcemia Due to Vitamin D Toxicity. (2025). https://doi.org/10.1210/jendso/bvaf149.486 https://doi.org/10.1210/jendso/bvaf149.486
7. [7] Health, financial and environmental impacts of unnecessary vitamin D testing: a triple bottom line assessment adapted for healthcare. (2022). https://doi.org/10.1136/bmjopen-2021-056997 https://doi.org/10.1136/bmjopen-2021-056997
8. [8] Vitamin D testing: advantages and limits of the current assays. (2020). https://doi.org/10.1038/s41430-019-0553-3 https://doi.org/10.1038/s41430-019-0553-3